tiprankstipranks
Trending News
More News >
Elite Pharmaceuticals (ELTP)
:ELTP
US Market

Elite Pharmaceuticals (ELTP) Income Statement

Compare
337 Followers

Elite Pharmaceuticals Income Statement

Last quarter (Q4 2025), Elite Pharmaceuticals's total revenue was $32.00M, an increase of 78.26% from the same quarter last year. In Q4, Elite Pharmaceuticals's net income was $17.00M. See Elite Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
$ 84.04M$ 56.63M$ 34.16B$ 32.26M$ 25.38M
Gross Profit
$ 40.09M$ 26.36M$ 16.59B$ 14.80M$ 11.87M
Operating Expenses
$ 20.49M$ 15.57M$ 12.92B$ 9.72M$ 9.76M
Depreciation and Amortization
$ 2.12M$ 1.47M$ 1.33M$ 1.42M$ 1.52M
EBITDA
$ 2.84M$ 2.58M$ 6.43M$ 6.27M$ 5.93M
Operating Income
$ 19.60M$ 10.79M$ 2.03B$ 5.07M$ 2.10M
Other Income/Expenses
$ -19.65M$ -10.33M$ 309.87K$ 1.23M$ 2.04M
Pretax Income
$ -52.14K$ 463.09K$ 3.99B$ 6.30M$ 4.14M
Net Income
$ -4.31M$ 20.11M$ 4.41B$ 8.90M$ 5.09M
Per Share Metrics
Basic EPS
$ -4.04$ 0.02$ 4.35$ 0.01$ 0.01
Diluted EPS
$ -4.04$ 0.02$ 4.35$ 0.01$ 0.01
Weighted Average Shares Outstanding
1.07B 1.02B 1.01B 1.01B 943.00M
Weighted Average Shares Outstanding (Diluted)
1.07B 1.02B 1.01B 1.01B 943.00M
Currency in USD

Elite Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis